Article Information
History
- April 7, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Noha Abdelgawad1,†,
- Sean Wasserman2,3,†,
- Mahmoud Tareq Abdelwahab1,
- Angharad Davis2,4,5,
- Cari Stek2,
- Lubbe Wiesner1,
- John Black6,
- Graeme Meintjes2,7,
- Robert J. Wilkinson2,3,4,8 and
- Paolo Denti1,#
- 1Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa
- 2Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Observatory 7925, South Africa
- 3Division of Infectious Diseases and HIV Medicine, Department of Medicine, University of Cape Town, Observatory 7925, South Africa
- 4The Francis Crick Institute, London NW1 1AT, United Kingdom
- 5Faculty of Life Sciences, University College London, WC1E 6BT, United Kingdom
- 6Department of Medicine, Walter Sisulu University, Mthatha, South Africa
- 7Department of Medicine, University of Cape Town, Observatory 7925, South Africa
- 8Department of infectious Diseases, Imperial College London W12 0NN, United Kingdom
- ↵#Address correspondence to Paolo Denti, paolo.denti{at}uct.ac.za.
↵† Contributed equally to this manuscript
Posted April 07, 2023.
Linezolid population pharmacokinetic model in plasma and cerebrospinal fluid among patients with tuberculosis meningitis
